Literature DB >> 17562579

From genes to brain: understanding brain development in neurogenetic disorders using neuroimaging techniques.

Marie Schaer1, Stephan Eliez.   

Abstract

For almost two decades, a considerable amount of work has been devoted to the accurate delineation of normal and abnormal brain development using cerebral MRI. In the broad field of neuroimaging research, specific genetic conditions associated with impaired cognitive performances or with psychiatric symptoms have received increased attention because of their potential for revealing insight on the biologic correlates of behavior. First delineated by volumetric measurements of cerebral lobes or regions of interest, new image processing techniques are currently defining cerebral phenotypes associated with neurogenetic disorders with increasing precision. In this article the authors review the contribution of structural brain imaging in advancing our understanding of the pathogenic processes underlying altered brain development in Down, fragile X, and velocardiofacial (22q11DS) syndromes.

Entities:  

Mesh:

Year:  2007        PMID: 17562579     DOI: 10.1016/j.chc.2007.02.002

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  10 in total

Review 1.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

2.  Velo-Cardio-Facial Syndrome.

Authors:  Doron Gothelf; Amos Frisch; Elena Michaelovsky; Abraham Weizman; Robert J Shprintzen
Journal:  J Ment Health Res Intellect Disabil       Date:  2009-04

Review 3.  Pharmacotherapy of Disruptive Behaviors in Children with Intellectual Disabilities.

Authors:  Gabrielle E Hodgins; Kristen Winsor; Jarrett Barnhill
Journal:  Paediatr Drugs       Date:  2022-07-04       Impact factor: 3.930

4.  Regional cortical volumes and congenital heart disease: a MRI study in 22q11.2 deletion syndrome.

Authors:  Marie Schaer; Bronwyn Glaser; Marie-Christine Ottet; Maude Schneider; Meritxell Bach Cuadra; Martin Debbané; Jean-Philippe Thiran; Stephan Eliez
Journal:  J Neurodev Disord       Date:  2010-09-14       Impact factor: 4.025

5.  Multidimensional morphometric 3D MRI analyses for detecting brain abnormalities in children: impact of control population.

Authors:  Marko Wilke; Douglas F Rose; Scott K Holland; James L Leach
Journal:  Hum Brain Mapp       Date:  2013-11-04       Impact factor: 5.038

Review 6.  Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).

Authors:  Edith M Jolin; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

Review 7.  Primary immunodeficiency diseases associated with neurologic manifestations.

Authors:  Soodabeh Fazeli Dehkordy; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2011-10-26       Impact factor: 8.542

8.  Brain tissue- and region-specific abnormalities on volumetric MRI scans in 21 patients with Bardet-Biedl syndrome (BBS).

Authors:  Kim M Keppler-Noreuil; Catherine Blumhorst; Julie C Sapp; Danielle Brinckman; Jennifer Johnston; Peggy C Nopoulos; Leslie G Biesecker
Journal:  BMC Med Genet       Date:  2011-07-27       Impact factor: 2.103

9.  Basal ganglia involvement in ARX patients: The reason for ARX patients very specific grasping?

Authors:  Aurore Curie; Gaëlle Friocourt; Vincent des Portes; Alice Roy; Tatjana Nazir; Amandine Brun; Anne Cheylus; Pascale Marcorelles; Kalliroi Retzepi; Nasim Maleki; Gérald Bussy; Yves Paulignan; Anne Reboul; Danielle Ibarrola; Jian Kong; Nouchine Hadjikhani; Annie Laquerrière; Randy L Gollub
Journal:  Neuroimage Clin       Date:  2018-04-05       Impact factor: 4.881

Review 10.  Neurological Manifestations of Primary Immunodeficiencies.

Authors:  Zahra Chavoshzadeh; Amir Hashemitari; Sepideh Darougar
Journal:  Iran J Child Neurol       Date:  2018
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.